- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroblastoma
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 2, Issue -, Pages 16078
Publisher
Springer Nature
Online
2016-11-10
DOI
10.1038/nrdp.2016.78
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN trial.
- (2017) R. L. Ladenstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression
- (2016) N. F. Evageliou et al. CLINICAL CANCER RESEARCH
- A Vision for Global Cancer Medicine: Pursuing the Equity of Chance
- (2016) Agnes Binagwaho et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial
- (2016) Steven G. DuBois et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2
- (2016) Nikolai Siebert et al. mAbs
- Applying 89Zr-Transferrin To Study the Pharmacology of Inhibitors to BET Bromodomain Containing Proteins
- (2016) Michael G. Doran et al. MOLECULAR PHARMACEUTICS
- Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
- (2016) John T. Powers et al. NATURE
- Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
- (2015) Christopher J. Lord et al. Annual Review of Medicine
- 131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study
- (2015) Gregory A. Yanik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study
- (2015) L L Wang et al. BRITISH JOURNAL OF CANCER
- Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
- (2015) Kristopher R. Bosse et al. CANCER
- Identification of patient subgroups with markedly disparate rates ofMYCNamplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project
- (2015) Daria Thompson et al. CANCER
- A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis
- (2015) Robert W. Schnepp et al. CANCER CELL
- Anaplastic Lymphoma Kinase as a Cancer Target in Pediatric Malignancies
- (2015) Y. P. Mosse CLINICAL CANCER RESEARCH
- Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
- (2015) S. G. DuBois et al. CLINICAL CANCER RESEARCH
- Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment
- (2015) I. Lambertz et al. CLINICAL CANCER RESEARCH
- Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition
- (2015) A. Henssen et al. CLINICAL CANCER RESEARCH
- Establishing neural crest identity: a gene regulatory recipe
- (2015) M. Simoes-Costa et al. DEVELOPMENT
- Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)
- (2015) Margaret J. Zhou et al. EUROPEAN JOURNAL OF CANCER
- Advances in Risk Classification and Treatment Strategies for Neuroblastoma
- (2015) Navin R. Pinto et al. JOURNAL OF CLINICAL ONCOLOGY
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
- (2015) Derek A. Oldridge et al. NATURE
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- Mutational dynamics between primary and relapse neuroblastomas
- (2015) Alexander Schramm et al. NATURE GENETICS
- TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
- (2015) Linda J Valentijn et al. NATURE GENETICS
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Pediatric reference intervals for plasma free and total metanephrines established with a parametric approach: Relevance to the diagnosis of neuroblastoma
- (2015) Laura Crosazzo Franscini et al. PEDIATRIC BLOOD & CANCER
- Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand–receptor interactions
- (2015) Andrey V. Reshetnyak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COX/mPGES-1/PGE2pathway depicts an inflammatory-dependent high-risk neuroblastoma subset
- (2015) Karin Larsson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma
- (2015) N. R. Infarinato et al. Cancer Discovery
- FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase
- (2015) Jikui Guan et al. eLife
- Cancer Stem Cells and Their Interaction with the Tumor Microenvironment in Neuroblastoma
- (2015) Evan Garner et al. Cancers
- Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
- (2015) Alex Cazes et al. Oncotarget
- Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: High incidence of endocrine and growth problems
- (2014) L E Cohen et al. BONE MARROW TRANSPLANTATION
- Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
- (2014) R Defferrari et al. BRITISH JOURNAL OF CANCER
- Childhood and adolescent cancer statistics, 2014
- (2014) Elizabeth Ward et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Drugging MYCN through an Allosteric Transition in Aurora Kinase A
- (2014) William Clay Gustafson et al. CANCER CELL
- ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
- (2014) Scott C. Bresler et al. CANCER CELL
- Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission
- (2014) Brian H. Kushner et al. CLINICAL CANCER RESEARCH
- Key role for myeloid cells: Phase II results of anti-GD2antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma
- (2014) Nai-Kong V. Cheung et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS)
- (2014) Wendy G. Mitchell et al. JOURNAL OF CHILD NEUROLOGY
- Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: A European HR-NBL1/SIOPEN Study
- (2014) Virginie F. Viprey et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma
- (2014) Fariba Navid et al. JOURNAL OF CLINICAL ONCOLOGY
- Emergence of New ALK Mutations at Relapse of Neuroblastoma
- (2014) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical, Biologic, and Prognostic Differences on the Basis of Primary Tumor Site in Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
- (2014) Kieuhoa T. Vo et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient-Specific Dosimetry Using Pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) Dynamic PET/CT Imaging Before [131I]mIBG Targeted Radionuclide Therapy for Neuroblastoma
- (2014) Shih-ying Huang et al. MOLECULAR IMAGING AND BIOLOGY
- Mechanisms of neuroblastoma regression
- (2014) Garrett M. Brodeur et al. Nature Reviews Clinical Oncology
- Genomic organization and evolution of double minutes/homogeneously staining regions withMYCamplification in human cancer
- (2014) Alberto L'Abbate et al. NUCLEIC ACIDS RESEARCH
- A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
- (2014) K Althoff et al. ONCOGENE
- Neuroblastoma with symptomatic epidural compression in the infant: The AIEOP experience
- (2014) Bruno De Bernardi et al. PEDIATRIC BLOOD & CANCER
- Second malignancies in patients with neuroblastoma: The effects of risk-based therapy
- (2014) Mark A. Applebaum et al. PEDIATRIC BLOOD & CANCER
- Does Aggressive Surgical Resection Improve Survival in Advanced Stage 3 and 4 Neuroblastoma? A Systematic Review and Meta-analysis
- (2014) Dhanya Mullassery et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Expression Quantitative Trait Loci and Receptor Pharmacology Implicate Arg1 and the GABA-A Receptor as Therapeutic Targets in Neuroblastoma
- (2014) Christopher S. Hackett et al. Cell Reports
- NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas
- (2014) Yusuke Suenaga et al. PLoS Genetics
- Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
- (2014) Ãngela Roco et al. Frontiers in Genetics
- Ultra-High Density SNParray in Neuroblastoma Molecular Diagnostics
- (2014) Inge M. Ambros et al. Frontiers in Oncology
- Is there a role for PET-CT and SPECT-CT in pediatric oncology?
- (2013) Martin Biermann et al. ACTA RADIOLOGICA
- A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children’s Oncology Group study ANBL00P1
- (2013) A E Seif et al. BONE MARROW TRANSPLANTATION
- Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
- (2013) Tal Teitz et al. CANCER RESEARCH
- Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma
- (2013) Tasnim Ara et al. CANCER RESEARCH
- Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
- (2013) Y. Liu et al. CLINICAL CANCER RESEARCH
- Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study
- (2013) J.A. Kohler et al. EUROPEAN JOURNAL OF CANCER
- Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study
- (2013) Angela Di Giannatale et al. EUROPEAN JOURNAL OF CANCER
- A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma
- (2013) Jayne S. Wilson et al. EUROPEAN JOURNAL OF CANCER
- Dependence receptor UNC5D mediates nerve growth factor depletion–induced neuroblastoma regression
- (2013) Yuyan Zhu et al. JOURNAL OF CLINICAL INVESTIGATION
- Iodine-123 Metaiodobenzylguanidine Scintigraphy Scoring Allows Prediction of Outcome in Patients With Stage 4 Neuroblastoma: Results of the Cologne Interscore Comparison Study
- (2013) Boris Decarolis et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Surgery in the Treatment of Patients With Stage 4 Neuroblastoma Age 18 Months or Older at Diagnosis
- (2013) Thorsten Simon et al. JOURNAL OF CLINICAL ONCOLOGY
- Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group
- (2013) G. A. Yanik et al. JOURNAL OF NUCLEAR MEDICINE
- Renal Carcinoma After Childhood Cancer: A Report From the Childhood Cancer Survivor Study
- (2013) Carmen L. Wilson et al. JNCI-Journal of the National Cancer Institute
- Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
- (2013) Susan G Kreissman et al. LANCET ONCOLOGY
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
- (2013) Yael P Mossé et al. LANCET ONCOLOGY
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Update on Pediatric Opsoclonus Myoclonus Syndrome
- (2013) Gudrun Schleiermacher et al. NEUROPEDIATRICS
- Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium
- (2013) Barry J. Maurer et al. PEDIATRIC BLOOD & CANCER
- Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project
- (2013) Yaël P. Mossé et al. PEDIATRIC BLOOD & CANCER
- Focal DNA Copy Number Changes in Neuroblastoma Target MYCN Regulated Genes
- (2013) Candy Kumps et al. PLoS One
- Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
- (2013) Alexandre Puissant et al. Cancer Discovery
- Neuroblastoma and MYCN
- (2013) M. Huang et al. Cold Spring Harbor Perspectives in Medicine
- A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants
- (2012) Jed G. Nuchtern et al. ANNALS OF SURGERY
- The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
- (2012) Teeara Berry et al. CANCER CELL
- Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
- (2012) Shizhen Zhu et al. CANCER CELL
- 1p36 Tumor Suppression--A Matter of Dosage?
- (2012) K.-O. Henrich et al. CANCER RESEARCH
- Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
- (2012) S. G. DuBois et al. CLINICAL CANCER RESEARCH
- Successful treatment of infants with localized neuroblastoma based on their MYCN status
- (2012) Tomoko Iehara et al. International Journal of Clinical Oncology
- Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
- (2012) Nai-Kong V. Cheung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
- (2012) Nidale Tarek et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641
- (2012) Douglas R. Strother et al. JOURNAL OF CLINICAL ONCOLOGY
- Trans-population Analysis of Genetic Mechanisms of Ethnic Disparities in Neuroblastoma Survival
- (2012) Eric R. Gamazon et al. JNCI-Journal of the National Cancer Institute
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
- (2012) Sharon J Diskin et al. NATURE GENETICS
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- (2012) Jan J Molenaar et al. NATURE GENETICS
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
- (2012) Mark Sausen et al. NATURE GENETICS
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
- (2012) Julie R. Park et al. PEDIATRIC BLOOD & CANCER
- Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors
- (2012) Marjolein van Waas et al. PLoS One
- Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
- (2012) L. J. Valentijn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes
- (2011) Christian P. Kratz et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
- (2011) C. U. Louis et al. BLOOD
- Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
- (2011) Hanna Kryh et al. BMC GENOMICS
- Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age
- (2011) Denah R. Taggart et al. JOURNAL OF CLINICAL ONCOLOGY
- Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study
- (2011) Julie R. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- 177Lu-DOTATATE Molecular Radiotherapy for Childhood Neuroblastoma
- (2011) J. E. Gains et al. JOURNAL OF NUCLEAR MEDICINE
- The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma
- (2011) Araz Marachelian et al. PEDIATRIC BLOOD & CANCER
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force
- (2010) K K Matthay et al. BRITISH JOURNAL OF CANCER
- Genotypes of NK Cell KIR Receptors, Their Ligands, and Fc Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy
- (2010) D. C. Delgado et al. CANCER RESEARCH
- Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study
- (2010) Wendy B. London et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
- (2010) Suzanne Shusterman et al. JOURNAL OF CLINICAL ONCOLOGY
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study
- (2010) Ruth Ladenstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma WithoutMYCNAmplification: Results of the Prospective INES 99.1
- (2010) Hervé Rubie et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group Study
- (2010) Rochelle Bagatell et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma
- (2010) David L. Baker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of advanced bone age in a cohort of patients who received cis-retinoic acid for high-risk neuroblastoma
- (2010) Wendy L. Hobbie et al. PEDIATRIC BLOOD & CANCER
- Diabetes Mellitus in Long-term Survivors of Childhood Cancer
- (2009) Lillian R. Meacham et al. ARCHIVES OF INTERNAL MEDICINE
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
- (2009) K Beiske et al. BRITISH JOURNAL OF CANCER
- Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
- (2009) Liping Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma WithoutMYCNGene Amplification
- (2009) Bruno De Bernardi et al. JOURNAL OF CLINICAL ONCOLOGY
- Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
- (2009) Kim Kramer et al. JOURNAL OF NEURO-ONCOLOGY
- 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma
- (2009) S. E. Sharp et al. JOURNAL OF NUCLEAR MEDICINE
- Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor Study
- (2009) Caroline Laverdière et al. JNCI-Journal of the National Cancer Institute
- Finding the missing heritability of complex diseases
- (2009) Teri A. Manolio et al. NATURE
- Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
- (2009) Colin J D Ross et al. NATURE GENETICS
- VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE)
- (2009) Franck Bourdeaut et al. PEDIATRIC BLOOD & CANCER
- Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells
- (2008) T. Ara et al. CANCER RESEARCH
- Interleukin-6 and Soluble Interleukin-6 Receptor Levels as Markers of Disease Extent and Prognosis in Neuroblastoma
- (2008) R. A. Egler et al. CLINICAL CANCER RESEARCH
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- Significance ofMYCNAmplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database
- (2008) Rochelle Bagatell et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study
- (2008) Eiso Hiyama et al. LANCET
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
- (2008) Andrew DJ Pearson et al. LANCET ONCOLOGY
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- Activating mutations in ALK provide a therapeutic target in neuroblastoma
- (2008) Rani E. George et al. NATURE
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- (2008) Martin A Pule et al. NATURE MEDICINE
- Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: A report from the Children's Oncology Group
- (2008) Peter E. Zage et al. PEDIATRIC BLOOD & CANCER
- Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: A report from the Children's Oncology Group
- (2008) Julie R. Park et al. PEDIATRIC BLOOD & CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started